Hiroko Kato‐Hayashi

Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy

Chiemi Hirose, Hironori Fujii, Hirotoshi Iihara et al. · Supportive Care in Cancer · 2020 · 31 citations · Full text

Quality Of Life, Family Medicine, Life Assessment +28

Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy

Hironori Fujii, Yukino Ueda, Chiemi Hirose et al. · Journal of Pharmaceutical Health Care and Sciences · 2022 · 26 citations · Full text

Comparative efficacy and safety of vancomycin versus teicoplanin in febrile neutropenic patients receiving hematopoietic stem cell transplantation

Hiroko Kato‐Hayashi, Takashi Niwa, Koichi Ohata et al. · Journal of Clinical Pharmacy and Therapeutics · 2019 · 16 citations

Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi‐institutional randomized controlled trial

Junichi Kitagawa, Ryo Kobayashi, Yasuyuki Nagata et al. · International Journal of Cancer · 2020 · 15 citations · Full text

Control Group, Cell Therapy, Oncology +14

Severe Neutropenia is Associated with Better Clinical Outcomes in Patients with Advanced Pancreatic Cancer Who Receive Modified FOLFIRINOX Therapy

Yunami Yamada, Hironori Fujii, Daichi Watanabe et al. · Cancers · 2018 · 12 citations · Full text